Bio-Connect
IHC-P analysis of mouse kidney tissue using GTX31943 JAK2 antibody. Working concentration : 5 microg/ml
IHC-P analysis of mouse kidney tissue using GTX31943 JAK2 antibody. Working concentration : 5 microg/ml
IHC-P analysis of mouse kidney tissue using GTX31943 JAK2 antibody. Working concentration : 5 microg/ml

JAK2 antibody

GTX31943
GeneTex
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetJAK2
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    JAK2 antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1 - 2 microg/mL. IHC-P: 5 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID3717
  • Target name
    JAK2
  • Target description
    Janus kinase 2
  • Target synonyms
    JTK10, tyrosine-protein kinase JAK2, JAK-2, Janus kinase 2 (a protein tyrosine kinase)
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDO60674
  • Protein Name
    Tyrosine-protein kinase JAK2
  • Scientific Description
    This gene product is a protein tyrosine kinase involved in a specific subset of cytokine receptor signaling pathways. It has been found to be constituitively associated with the prolactin receptor and is required for responses to gamma interferon. Mice that do not express an active protein for this gene exhibit embryonic lethality associated with the absence of definitive erythropoiesis. [provided by RefSeq, Jul 2008]
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Wu R, Wang C, Li Z, et al. SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA. J Immunother Cancer. 2020,8(2). doi: 10.1136/jitc-2020-001037
    Read this paper